Comparison of Movement Pattern Training and Manual Therapy for Prearthritic Hip Disorders

Not Applicable

Completed

• Conditions: Dysplasia Mild; Prearthritic Hip Disorder; Hip-related Groin Pain; Femoroacetabular Impingement
• Interventions: Other: Manual Therapy; Other: Movement Pattern Training

• Registration Number: NCT03959319
• Lead Sponsor: Washington University School of Medicine

Brief Summary

Significance: Intra-articular, prearthritic hip disorders (PAHD) result in substantial dysfunction in young adults and are proposed precursors to hip osteoarthritis (OA). Our long term goal is to develop effective treatment strategies for people with PAHD that will improve function, decrease pain and prevent or delay the onset of OA. The purpose of this study is to compare movement pattern training (MoveTrain) and manual therapy (ManTher) in their effect on post-treatment, patient-reported outcomes and targeted impairments thought to contribute to PAHD.

This pilot study will collect sufficient data to power a future study that will determine the efficacy of MoveTrain compared to ManTher for people with PAHD. Participants with PAHD will be randomized into one of two treatment groups, MoveTrain or ManTher. The Hip disability and Osteoarthritis Outcome Score (HOOS) will be the primary outcome measure. A measure of hip adduction motion during functional tasks and quantitative sensory assessment (pain pressure threshold and temporal summation) will be the secondary measures used to assess the effect of respective treatment on the impairments thought to contribute to PAHD, thus addressing the mechanisms of pain. Upon completion of this study, we will be positioned to implement a large RCT (randomized clinical trial) to definitively assess the efficacy of MoveTrain and ManTher to improve PAHD.

Specific Aims: To obtain preliminary estimates of effect sizes for planning the future definitive randomized clinical trial,

Aim 1 (Function): we will compare post-treatment improvements in hip-specific, patient-reported outcomes among the two treatment groups. After treatment completion:

Aim 2 (Mechanism): we will compare pre- and post-treatment measures in lower extremity movement patterns during functional tasks (MoveTrain) and quantitative sensory testing (ManTher). After treatment completion:

Aim 3 (Prognosis): we will determine the association among personal factors at baseline (demographic and psychosocial) and treatment prognosis (improvement in HOOS).

Impact: Our line of research will improve our understanding of each proposed treatment and its effect on patient function and each treatment's targeted impairment. This improved understanding will lead to the development of treatment strategies that will ultimately result in comparative effectiveness studies of surgical and non-surgical treatment.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2019-05-20
• Study First Submitted QC: 2019-05-20
• Study First Posted: 2019-05-22
• Study Start: 2019-07-01
• Primary Completion: 2022-12-31
• Study Completion: 2022-12-31
• Status Verified: 2023-01
• Last Update Submitted: 2023-01-27
• Last Update Posted: 2023-01-31

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 33

Inclusion Criteria

• Age 18-40 years

  • Must be scheduled before their 40th birthday

• Have frequent hip joint symptoms, defined as pain, aching or stiffness within the hip joint for at least 3 months during the past 12 months

• Hip joint pain confirmed upon physical exam

• Report pain >= 3/10

• Reports functional limitation as demonstrated by modified Harris Hip Score <90

• Has protective sensation in the feet

Read More

Exclusion Criteria

• Previous hip surgery, fracture, pelvic/hip infection or cancer

• Pain due to high impact trauma

• Inflammatory disease, e.g. rheumatoid arthritis, gout

• Acute pain in another joint that limits functional activities

• Perthes disease or slipped capital femoral epiphysis

• Hip pain referred from another source, e.g. lumbar spine

• Neurological involvement affecting balance or coordination

• Use of assistive gait device for more than 50% of time walking

• Pain, numbness or tingling in the lower extremity

• Pregnancy or given birth in previous 12 weeks

• Unwilling to refrain from taking NSAIDs 1-2 days prior to testing session

• Unable to attend regular physical therapy sessions

• Unable to complete 12 month follow up session

  • Avascular Necrosis
  • Ehler's Danlos Syndrome

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Manual Therapy (Joint Mobilization)	Manual Therapy	Focus will be on reducing pain and improving pain-free range of motion using manual techniques provided by the physical therapist and exercise performed in the home program. Patient education will include instruction to the benefits of manual therapy and the proposed effects on pain and joint mobility. Joint mobilizations to be used with each patient will be prioritized based on the restrictions, defined as stiffness or pain that is limiting joint range of motion, noted on the patient's baseline examination. For example, during the first visit, the treating physical therapist will begin with the two most restricted motions noted in the baseline exam and perform a standard assessment to determine treatment parameters. The home program will include joint range of motion and stretching exercises to complement techniques performed during the supervised sessions.
Movement Pattern Training	Movement Pattern Training	Focus will be on task-specific training to improve lower extremity movement patterns during basic daily tasks, such as sit to stand and stairs, and reported patient-specific tasks. Patient education will include instruction in abnormal movement patterns and methods to optimize movement patterns during each task. Tasks will be prioritized based on patient-report of activity limitations during the baseline examination. For example, during the first visit, the treating physical therapist will begin with the daily and patient-specific tasks that the patient reported as being most bothersome. Exercises will include repeated practice of functional tasks using optimized movement patterns. Based on the participant's performance, the difficulty of the task-specific activities will be progressed by varying the repetitions performed, increasing the load or changing the support surface. The home program will consist of repeated practice of tasks performed during the supervised sessions.

Primary Outcome Measures

Name	Time	Method
Change in Function Using the Hip disability and Osteoarthritis Outcome Score Symptom Subscale	Immediately after treatment (13 weeks after baseline)	The Hip disability and Osteoarthritis Outcome Score (HOOS) is a hip-specific patient-reported outcome measure that has 5 subscales. Each subscale is score separately and ranges from 0-100, 100 = no disability, therefore higher values indicate a better outcome.
Percentage of Participants Who Are Adherent to Treatment Attendance	Immediately after treatment (13 weeks after baseline)	Percentage of study participants who attend 90% (9/10) of the supervised treatment sessions.
Retention Rate	Immediately after treatment (13 weeks after baseline)	Percentage of those enrolled at baseline who completed testing after treatment
Change in Function Using the Hip disability and Osteoarthritis Outcome Score Activities of Daily Living Subscale	Immediately after treatment (13 weeks after baseline)	The Hip disability and Osteoarthritis Outcome Score (HOOS) is a hip-specific patient-reported outcome measure that has 5 subscales. Each subscale is score separately and ranges from 0-100, 100 = no disability, therefore higher values indicate a better outcome.

Secondary Outcome Measures

Name	Time	Method
Change in hip adduction angle	On year after treatment completion	Change in hip adduction angle during functional tasks. Variable to assess movement pattern changes.
Change in pain pressure threshold	One year after treatment completion	Pain pressure threshold is assessed with an algometer. This is a quantitative sensory testing to assess the patient's sensitivity to stimuli.
Change in Function Using the Hip disability and Osteoarthritis Outcome Score Pain Subscale	One year after treatment completion	The Hip disability and Osteoarthritis Outcome Score (HOOS) is a hip-specific patient-reported outcome measure that has 5 subscales. Each subscale is score separately and ranges from 0-100, 100 = no disability, therefore higher values indicate a better outcome.
Home Exercise Program (HEP) adherence	Immediately after treatment (13 weeks after baseline)	Participants were instructed to perform their HEP 5 times per week1 time per day. The variable for HEP adherence was calculated as the total number of days reported by the participant to have completed the prescribed exercises, summed over the entire treatment period, and divided by the total number of treatment days.
Patient treatment receipt	Immediately after treatment (13 weeks after baseline)	The total number of exercises the physical therapist reviewed and the total number of those exercises they rated as independent were each summed across all treatment visits to derive the percent of exercises rated as independent across the entire treatment (Σ independent / Σ reviewed \* 100).
Active ingredients for treatment delivery	Immediately after treatment (13 weeks after baseline)	Treatment delivery assessed using chart reviews to determine if the active ingredients of the treatment was provided. The variable for treatment delivery is the proportion of active ingredients completed and documented by the treatment physical therapists for XX treatment visits
Change in Function Using the Hip disability and Osteoarthritis Outcome Score Sport and Recreation Subscale	One year after treatment completion	The Hip disability and Osteoarthritis Outcome Score (HOOS) is a hip-specific patient-reported outcome measure that has 5 subscales. Each subscale is score separately and ranges from 0-100, 100 = no disability, therefore higher values indicate a better outcome.
Change in Function Using the Hip disability and Osteoarthritis Outcome Score Quality of Life Subscale	One year after treatment completion	The Hip disability and Osteoarthritis Outcome Score (HOOS) is a hip-specific patient-reported outcome measure that has 5 subscales. Each subscale is score separately and ranges from 0-100, 100 = no disability, therefore higher values indicate a better outcome.
Change in Function Using the Hip disability and Osteoarthritis Outcome Score Activities of Daily Living Subscale	One year after treatment completion	The Hip disability and Osteoarthritis Outcome Score (HOOS) is a hip-specific patient-reported outcome measure that has 5 subscales. Each subscale is score separately and ranges from 0-100, 100 = no disability, therefore higher values indicate a better outcome.
Change in Function Using the Hip disability and Osteoarthritis Outcome Score Symptom Subscale	One year after treatment completion	The Hip disability and Osteoarthritis Outcome Score (HOOS) is a hip-specific patient-reported outcome measure that has 5 subscales. Each subscale is score separately and ranges from 0-100, 100 = no disability, therefore higher values indicate a better outcome.
Change in movement evoked pain	One year after treatment completion	Movement evoked pain was assessed as a Numeric Pain Rating Scale (NPRS) after performance of a repetitive step down task and a repetitive deep squat task.
Change in Function Using the International Hip Outcome Tool (iHOT-33)	One year after treatment completion	The iHOT is a hip-specific patient-reported outcome measure that represents the patient's report of symptoms, activity limitations, as well as emotional and social status. the score ranges from 0-100, 100 = no disability, therefore higher values indicate a better outcome.
Change in Function Using the Patient Specific Functional Scale From Baseline to Post-treatment (13 Weeks)	Immediately after treatment (13 weeks after baseline)	The Patient Specific Functional Scale (PSFS), a patient-reported outcome measure of patient-specific activity limitations. Patients are asked to identify "3-5 activities you are unable to do or having difficulties performing due to the pain or symptoms in your hip". Patients then rated level of difficulty from 0-10, 0 indicating they are unable to perform the activity and 10 indicating they are able to perform the activity at their preinjury level. The final score is an average of all scores provided. Change was calculated by subtracting the baseline PSFS from the post-treatment PSFS.
Change in Function Using the Patient Specific Functional Scale From Baseline to Post-treatment	One year after treatment completion	The Patient Specific Functional Scale (PSFS), a patient-reported outcome measure of patient-specific activity limitations. Patients are asked to identify "3-5 activities you are unable to do or having difficulties performing due to the pain or symptoms in your hip". Patients then rated level of difficulty from 0-10, 0 indicating they are unable to perform the activity and 10 indicating they are able to perform the activity at their preinjury level. The final score is an average of all scores provided. Change was calculated by subtracting the baseline PSFS from the post-treatment PSFS.
Change in Average Pain Intensity Quantified by a Numeric Pain Rating Scale (NPRS) From Baseline to Post-treatment	One year after treatment completion	The numeric pain rating scale (NPRS) is a patient-reported outcome measure of pain intensity quantified using a 0-10 scale, 0 indicating the patient perceives no pain and 10 indicating the patient perceives the pain to be "worst pain imaginable". For average NPRS, patients are asked to rate what their pain was over the last week. Change was calculated by subtracting the baseline average NPRS from the post-treatment average NPRS.
Change in Worst Pain Intensity Quantified by a Numeric Pain Rating Scale (NPRS) From Baseline to Post-treatment	One year after treatment completion	The numeric pain rating scale (NPRS) is a patient-reported outcome measure of pain intensity quantified using a 0-10 scale, 0 indicating the patient perceives no pain and 10 indicating the patient perceives the pain to be "worst pain imaginable". For worst NPRS, patients are asked to rate what was their worst (highest) level of pain was over the last week. Change was calculated by subtracting the baseline worst NPRS from the post-treatment worst NPRS.

Trial Locations

Locations (1)

Program in Physical Therapy, Washington University; 🇺🇸 Saint Louis, Missouri, United States